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Abstract	

	

Background:  We describe a whole genome sequencing study of  one 
family containing two affected male children,  aged 10 and 12,  with 
severe intellectual disability, autism-like behavior, and very distinctive 
facial  features.  High  accuracy  is  of  paramount  importance  in  the 
context of detecting or discovering the genetic influencers of human 
disease, yet each sequencing and analysis pipeline is still imperfect.  In 
this study, we leverage data from two sequencing platforms and many 
data processing and downstream analysis pipelines to more confidently 
identify variants that may play an influential role in the disease state of 
these two children.	

Presentation of the phenotype	

	

The  propositi  are  two  affected  male  brothers  (Fig.  1),  aged  10  and  12 
respectively,  with  severe  intellectual  disability,  autism-like  behavior, 
attention  deficit  issues,  and  very  distinctive  facial  features  (Fig.  1), 
including  broad,  upturned  nose,  sagging  cheeks,  downward  sloping 
palpebral fissures, relative hypertelorism, high-arched palate, and prominent 
ears.  Their  parents are nonconsanguineous and are both healthy,  and the 
family history does not demonstrate any members with anything resembling 
this current syndrome.	

Fig. 1  Facial phenotype of the younger brother at age 19 months (A), 
3.5 years (a) and 7 years (a) ; and the elder brother at age 3 years (B), 5 
years  (b)  and  9  years  (b).   A  pedigree  displaying  intra  familial 
relationships.	

	

Complete Genomics WGS	

	

Whole  genomes  of  the  mother,  father  and 
both  affected  boys  were  sequenced  and 
analyzed  with  the  Complete  Genomics 
WGS  sequencing  and  bioinformatics 
pipeline.  Reads  were  mapped  to  the 
Genome  Reference  Consortium  assembly 
GRCh37.  Due  to  the  proprietary  data 
formats,  all  the  sequencing  data  QC, 
alignment  and  variant  calling  were 
performed by CG as part of their sequencing 
service,  using  their  version  2.0  pipeline. 
Complete Genomics WGS was optimized to 
cover 90% of the exome with 20 or more 
reads  and 85% of  the  genome with  20 or 
more reads. 	

Illumina WGS	

	

Whole  genomes  of  the  entire  pedigree 
were  sequenced  using  the  Illumina 
HiSeq2000.  WGS  covered  >90%  of  the 
genome with 30 reads or more and with 
>80% of the bases having a quality score 
of >30. Illumina reads were mapped to the 
hg19  reference  genome  using  BWA  v. 
0.6.2-r126,  and  variant  detection  was 
performed using the GATK v.  2.4-9.   A 
second  analytical  pipeline  was  used  to 
map reads to the hg19 reference genome 
using  Novoalign,  and  variants  were 
detected using the FreeBayes caller. 	

Methods: Whole genome sequencing (WGS) was performed on ten members of 
this family using the Illumina HiSeq2000 platform, with four (the two affected 
boys  and  their  parents)  being  additionally  sequenced  using  the  Complete 
Genomics (CG) WGS platform. CG data analysis was performed by CG, using 
their version 2.0 pipeline. Illumina reads were mapped to the hg19 reference 
genome using BWA v.0.6.2-r126, and variant detection was performed using 
the GATK v. 2.4-9. A second analytical pipeline was used to map the Illumina 
reads and detect variants using Novoalign and the FreeBayes caller. Disease 
variant  discovery  procedures  included  traditional  filtering  techniques  (using 
ANNOVAR  and  Golden  Helix  SVS),  and  a  statistical  framework  for 
identifying the likely disease causing variants (using VAAST). 	

Results: CG WGS covered >85% of the genome and >90% of the exome, 
both with 20 or more reads. Illumina WGS covered >90% of the genome 
with 30 reads or more and with >80% of the bases having a quality score of 
>30. We found a ~2 to 5-fold difference in the number of variants detected 
as being relevant for various disease models when using different sets of 
sequencing data and analysis pipelines. In one instance, employing a ‘quad’ 
study design reliably identified three putative variants that followed an X-
linked disease model, in TAF1, ZNF41 and ASB12 respectively.  However, 
ZNF41 and ASB12 variants were subsequently found to be false positive 
findings  when  the  study  expanded  to  include  more  family  members  and 
more data from each. 	

Bioinformatics analysis	

	

Bioinformatics  analyses  of  multiple  disease  model  pathways  were  performed in 
order  to  prioritize  and  identify  any  putative  mutations  that  might  aid  in  better 
understanding the pathogenesis of the described syndrome. We performed analyses 
to interrogate variants conforming to a de-novo, autosomal recessive and x-linked 
model of disease transmission. 	

	

We used several methods to prioritize and identify potentially disease contributing 
germ-line  mutations,  including  VAAST,  Golden  Helix  SVS,  ANNOVAR  and 
CADD,  a  integrative  tool  for  scoring  single  nucleotide  variants  and  insertion/
deletions.  VAAST employs a likelihood-based statistical framework for identifying 
the most likely disease contributing variants given genomic makeup and population 
specific  genomic  information.    SVS  and  ANNOVAR  employ  more  traditional 
filtering techniques that leverage data stored in public genomic databases.	

Conclusions: Using multiple sequencing and bioinformatics pipelines provides greater 
power in reducing false positive findings in the context of WGS studies - biological 
conclusions can shift between sequencing smaller to larger portions of a family.	

Using information from a greater portion of the family structure: 
17726 Variants were found to be de-novo in the two affected boys  
40 were coding : 
32 non-synonymous missense 
3 splicing  
2 frame-shift deletions 
1 stop-loss 
1 frame-shift insertion 
1 frame-shift substitution 
2824 Variants were found to conform to an X-linked disease model 
4 were coding: 
3 non-synonymous missense 
1 splicing 
Using only nuclear family: 
55195 Variants were found to be de-novo in the two affected boys  
122 were coding : 
107 non-synonymous missense 
4 splicing  
3 frame-shift deletions 
3 frame-shift insertions 
2 frame-shift substitutions 
2 stop-gain  
1 stop-loss 
26514 Variants were found to conform to an X-linked disease model 
28 were coding: 
27 non-synonymous missense 
1 splicing 
